Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Research Articles

Patients with type I or II diabetes are more likely to develop cardiovascular diseases (CVD), such as coronary heart disease (CHD). Heart conditions are particularly prevalent in patients with poorly managed diabetes. In fact, coronary heart disease is the leading cause of death in diabetic patients, accounting for around 80% of total deaths.

Apart from cardiovascular diseases (e.g. heart attacks), diabetic patients are also at a higher risk of developing hypertension (high blood pressure), strokes, and vascular problems (such as poor circulation). Similar to diabetes, cardiovascular diseases can be asymptomatic. This is why they often go undetected. According to a 2017 report published by Diabetes UK, middle-aged men who have diabetes are five times more likely to develop cardiovascular diseases. Female diabetic patients, on the other hand, are eight times more likely to have a CVD. In addition, over half of the patients who have type II diabetes show signs of cardiovascular disease complications during diagnosis. Many people have the misconception that heart conditions only affect the elderly. In reality, even diabetes patients under 30 years old may get cardiovascular diseases. Both type I and II diabetes can increase the risk of developing heart conditions.

Risk factors

It is believed that hyperglycemia (which characterizes diabetes) along with other risk factors such as free fatty acids in the blood may alter the composition of blood vessels. This significantly increases the risk of CVD. At the same time, the thickness of blood vessel lining may increase, thereby impairing blood flow. In general, diabetics are more likely to experience heart problems and strokes.

Symptoms of cardiovascular disease

Cardiovascular disease is usually characterized by symptoms such as swelling of ankles, irregular heartbeat, short of breath and chest pain. To be diagnosed with a cardiovascular disease, patients are required to take an electrocardiogram (EKG). Angina (or chest pain) is one of the main symptoms of coronary heart disease. There are two major form forms of angina: stable and unstable angina. Stable angina may cause transient pain in the chest (e.g. heavy, dull or tight pain) that lasts for several minutes. The pain is often triggered by factors such as cold weather, stress or physical activity. Patients should see a doctor right away if they experience signs of stable angina.

If the symptom persists for more than five minutes (or occurs in the absence of triggers), the patient may have unstable angina. Seek medical help urgently in the case of a suspected unstable angina. In contrast, heart attacks are commonly a result of a clot that prevents blood supply to the heart. Some of the main symptoms of heart attacks are tightness of chest, coughing, shortage of breath or intense pain in the center of the chest. Occasionally, patients may also experience anxiety.

Reducing the risk

It is possible to reduce the risk of cardiovascular diseases through lifestyle modifications such as dietary change and exercise. At the same time, smoking cessation is known to lower the risk of developing CVD in diabetic individuals. Diabetes patients should also limit their alcohol intake in order to prevent heart conditions. Patients should devise the prevention plan based on medical advice. As a precaution, diabetics are advised to check their blood pressure and cholesterol level at least one time a year. Perhaps more importantly, patients should keep their blood glucose levels under control. This is essential in both diabetes treatment and prevention of CVD. Research has shown that a 1% reduction of HbA1c may decrease the risk of cardiovascular disease by as much as 16% in patients with type II diabetes.

Additionally, pharmacological interventions may help to reduce the risk of cardiovascular disease. This includes medications such as low-dose aspirin, statins, calcium channel blockers, and ACE (angiotensin-converting enzyme) inhibitors.

Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.

Diabetes, Research
Tailored Effectiveness of Rybelsus (Semaglutide) Across Diverse Patient Profiles: A Comprehensive Overview

Sarah, 72, discovered a life-changing improvement in managing her type 2 diabetes and obesity with Rybelsus. It simplified her routine, boosting her vitality and energy levels while effectively managing her…

Read More
Insulin, Research, Type
Trulicity and A1C Reduction: What to Expect

A1C blood test provides an average measure of blood sugar levels over two to three months. A1C represents the percentage of hemoglobin molecules that have glucose attached to them. The…

Read More
Diabetes, General Health,
Empowering Global Health: World Diabetes Day Unveiled

Celebrated annually on November 14 National day, World Diabetes Day serves as a platform to amplify the voice for diabetes and commemorate the milestones that have shaped our understanding of…

Read More
Cancer, Diabetes, General
What is the Connection Between Diabetes and Breast Cancer? Exploring the Research and Expert Insights

In the vast realm of health, the interplay between different diseases can often surprise us. One such connection that has piqued the curiosity of researchers is the intriguing relationship between…

Read More
News, Research
Make an Impact: Support World Brain Day, July 22

Sean’s journey with brain injury“Started out all good, and then I had a freak accident. I fell, and when I met the water, it felt like I was hitting concrete,”…

Read More
Diabetes, Diabetes Tests,
How Effective Is Rybelsus as an alternative to Ozempic

Is Rybelsus the best alternative to Ozempic? When managing Type 2 Diabetes, the choice between Rybelsus and Ozempic is crucial. Both medications contain semaglutide, but their forms and efficacy vary. Let’s explore how Rybelsus stacks up…

Read More
Announcement, Diabetes, Diabetes
Research Says, You Can Now Generate Power with Blood Sugar

Did you know that extra glucose from your body can now generate electricity? Sounds like science fiction, isn’t it? However, research since 2016 supports the idea of using blood sugar…

Read More
Diabetes, Insulin, Research,
Get Ready For These New Once-Weekly Insulin Injections for Better Blood Sugar Management

Are you tired of injecting insulin daily? Then you may be happy to know that this problem will not last for too long. Researchers are in the process of introducing…

Read More
Announcement, Diabetes, News,
Artificial pancreas successfully trialed to manage blood sugar levels in type 2 diabetes

Here’s another breakthrough in the world of diabetes research, and this one is about the long-awaited artificial pancreas. Researchers from the Wellcome-MRC Institute of Metabolic Science at the University of…

Read More
Announcement, Insulin, News,
ARE YOU USING OZEMPIC FOR WEIGHT LOSS? THINK TWICE!

Ozempic and Weight LossOzempic is an FDA-approved medicine that treats type 2 diabetes and manages blood sugar. It is specifically designed for better glycemic control and to prevent complications concerning…

Read More